| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biomarin Pharmaceutical Inc. (BMRN) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. BMRN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 159.4K | $8.86M | - | |
| VP | 80.0K | $4.44M | - | |
| VP | 55.1K | $3.06M | - | |
| Dir | 49.4K | $2.74M | - | |
| Dir | 46.4K | $2.58M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 10, 2023 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 60,000 | $94.89 | $5,693,370.51 | -2.7% | -4.8% | -14.1% | |
| Apr 10, 2023 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 10,000 | $99.56 | $995,600.00 | -2.3% | -12.8% | -9.3% | |
| Apr 6, 2023 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 10,000 | $96.13 | $961,300.00 | -2.3% | -12.4% | -12.7% | |
| Apr 3, 2023 | Lawlis V Bryan53 | Director | Sale+OE | 8,500 | $97.09 | $825,265.00 | -22.7% | -11.1% | -10.1% | |
| Mar 13, 2023 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 23,000 | $91.64 | $2,107,800.00 | -2.3% | +3.7% | -5.4% | |
| Feb 13, 2023 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 21,000 | $109.84 | $2,306,550.00 | -3.2% | -12.7% | -21.0% | |
| Jan 25, 2023 | Ajer Jeffrey Robert58 | EVP, Chief Commercial Officer | Sale+OE | 49,000 | $115.70 | $5,669,133.50 | -36.2% | -17.6% | -21.4% | |
| Jan 17, 2023 | Bienaime Jean Jacques68 | Chief Executive Officer | Sale+OE | 20,000 | $111.90 | $2,238,000.00 | -3.0% | -10.2% | -16.4% | |
| Jan 13, 2023 | Mueller Brian64 | EVP, Chief Financial Officer | Sale+OE | 2,500 | $114.50 | $286,250.00 | -8.3% | -12.8% | -17.2% | |
| Dec 13, 2022 | Mueller Brian64 | EVP, Chief Financial Officer | Sale+OE | 2,500 | $107.50 | $268,750.00 | -8.3% | -15.9% | -8.0% |